Alzheimer's drugs are being tried on people in the early stages of the disease, Schneider said. "But they are pathologically already well along," he said. Starting therapy earlier might give some benefit, he noted, which would make a marker such as low leptin levels a useful indicator for preventive therapy.
Latest news and basic facts about Alzheimer's disease are available from the Alzheimer's Association.
Copyright © 2011 HealthDay. All rights reserved.